The Vietnam Association of Seafood Exporters and Producers said that it is preparing documents to sue the US Department of Commerce over its final conclusion in the 10th administrative review of anti-dumping duties on shrimp products imported from Vietnam.
According to regulations, Vietnam has the right to submit a file to the US International Commerce Court within 30 days.
VASEP said Vietnam does not dump shrimp in the US, so it will sue the DOC to ask for the tariff to be brought back to the zero level.
According to the Vietnam Competition Authority under the Ministry of Industry and Trade, POR10 was applied to frozen shrimp shipments imported into the US from February 1, 2014, to January 31, 2015.
Voluntary respondents are subject to an anti-dumping duty rate of 4.78 percent while the tariff imposed on other Vietnamese firms or exporters remains at 25.76 percent.
It added that the United States had significantly increased the duty rate for Vietnamese shrimp in the POR10, from 0.91 percent in the POR9 to 4.78 percent at present.
The main reason for the significant increase is the DOC’s continued application of differential pricing, allowing it reuse the zeroing method to calculate the dumping margins.
Full Content: Taipei Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Microsoft Moves Closer to Settling EU Antitrust Case Over Teams Integration
May 18, 2025 by
CPI
Meta Moves to Dismiss FTC Antitrust Case Amid Ongoing Trial
May 18, 2025 by
CPI
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas